My primary interest lies in the treatment of genetic diseases, which inspired me to focus on the development of the CRISPR system. I aspire to contribute to something meaningful, enhancing both the field and my own utility in it. The CRISPR system has proven, especially in recent years, to offer solutions for many previously untreatable diseases and to improve patients' quality of life. Therefore, advancing this technology is crucial for its widespread application. Alongside my colleagues, I have participated in numerous related projects, with my work on Cas12a proteins being particularly significant to me. I thoroughly enjoy laboratory work, especially cell manipulation, but I also find the analysis of next-generation sequencing (NGS) data to be both fascinating and enjoyable.